Company Category: Life Sciences

Turner Imaging Systems

Turner Imaging Systems engineers advanced portable imaging systems, bringing hospital-grade performance to the point of care. SMART-C® mini C-arm provides wireless, ultra-portable fluoroscopy for surgeons, orthopedics, and sports medicine. ENDURO™ DR offers robust digital radiography in a compact size for hospitals, urgent care, and mobile settings. Both accelerate diagnoses, streamline workflows, and help improve patient experiences and outcomes wherever imaging is needed. | Turner Imaging Systems is redefining medical imaging with portable solutions that empower providers to deliver fast, precise care — wherever it’s needed. Our flagship SMART-C® is the world’s most portable and only battery-powered mini C-arm. Weighing just 16 lbs, it delivers high-definition fluoroscopy at the point of care — in clinics, operating rooms, or even the field — without the cords or limitations of traditional systems. Complementing the SMART-C, the ENDURO™ DR series offers high-performance digital radiography designed for speed, precision, and seamless workflow integration. With hospital-grade imaging, rapid acquisition, and cordless portability, ENDURO DR is built for any care setting. We proudly support healthcare professionals in orthopedics, emergency medicine, podiatry, veterinary care, and beyond — delivering advanced imaging solutions engineered for today’s fast-moving healthcare environment and with patient experience at the forefront. Discover how Turner Imaging Systems is advancing portable imaging at turnerxray.com.

Read More

TubeWriter

TubeWriter labeling systems is a full-feature instrument for printing directly at high-speed on the sides and caps of plastic, glass, and curved surfaces, including tubes, vials, slides, plates and custom labware. It is designed to address automating laboratory printing for assays, protocols and experiments. TubeWriter labeling withstands the harshest of lab conditions; resistant to chemical solvents and surviving long-term storage at -80C and liquid nitrogen. | TubeWriter is an automated labeling systems that prints directly on the surface of any labware eliminating the need for sticky labels. For laboratories that perform medium to high-throughput applications struggling with manual labeling or paper labels, the TubeWriter prints directly on the sides and caps of tubes, vials, plates and unique labware. TubeWriter prints text, images, and barcodes using UV-curable ink that withstands extreme lab conditions, most harsh chemicals and long-term storage at -80C and liquid nitrogen.

Read More

TruDiagnostic

TruDiagnostic Most biomarkers tell you where a patient is right now. DNA methylation tells you where they’re headed and why. TruDiagnostic is a CLIA-certified epigenetics lab and research partner specializing in DNA methylation analysis for biological age, disease risk, and multi-system health performance. Founded in 2020, we’ve built one of the largest private methylation datasets in the world: 200,000+ participants, 80+ published studies, and 115+ active research collaborators – including institutions publishing in Nature Aging and peer-reviewed clinical journals. Our positioning is deliberate: science over commercialization. Every product we offer is grounded in rigorous, independently validated research. What we bring to the table for our partners: Our Epigenetic Biomarker Proxies (EBPs) predict 2,000+ protein and metabolite biomarkers directly from a blood spot. In head-to-head comparisons, these DNA Methylation derived biomarkers outperform traditional direct measurements 62% of the time, with better effect sizes and greater signal stability. Unlike point-in-time assays, methylation patterns reflect long-term biological averages, making them less susceptible to day-to-day biological noise. Our Methylation Risk Scores (MRS) predict 5- and 10-year disease risk with ~90% accuracy across cardiovascular disease, diabetes, Alzheimer’s, Parkinson’s, and cognitive decline. Unlike polygenic risk scores, MRS are modifiable — they respond to interventions, making them uniquely actionable for clinical trials, therapeutic validation, and personalized medicine applications. Our immune deconvolution platform reconstructs cell-type composition from whole blood with only a 3% error rate compared to flow cytometry, at a fraction of the cost and complexity. We collaborate across pharma, consumer health, and clinical research. Deliverables include processed IDAT files and beta values, custom aging clocks, organ-specific risk scores, cohort-level analysis reports, and intervention efficacy assessments. Our work with Olaplex on tissue-specific skin aging demonstrates how this technology extends well beyond blood. If you’re running clinical trials, building risk stratification tools, or looking for a methylation data partner with the depth to support real discovery, we’re built for that conversation.

Read More

Trinzz

Trinzz builds the foundational data layer for medical AI. We create clinical-grade, regulatory-ready datasets through expert-led annotation workflows and multi-layer quality control across multimodal imaging. By combining domain specialists with structured validation pipelines, we enable healthcare AI teams to move from training environments to real-world clinical deployment with confidence.

Read More

Tri-Imaging Solutions

Tri-Imaging Solutions is a trusted global partner in the diagnostic imaging industry, delivering innovative imaging parts, equipment solutions, technology-driven service support, and state-of-the-art training. Following the strategic integration of DirectMed Imaging, our combined organization brings expanded inventory, deeper technical expertise, and enhanced support capabilities to healthcare providers. With a growing footprint and multiple distribution hubs, we provide fast, reliable access to critical components while equipping in-house teams with the tools and expertise needed to improve efficiency and reduce costs. Our mission is simple: to strengthen healthcare organizations through smarter, more strategic imaging solutions.

Read More

Translational Genomics Research Institute (TGen), part of City of Hope

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help patients through efficiency and effectiveness of the translational process. For more information, visit: tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen. | About TGen, part of City of Hope Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is part of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help patients through efficiency and effectiveness of the translational process. For more information about TGen, follow us on Facebook, BlueSky, Instagram and LinkedIn.

Read More

TransGen Biotech Co., Ltd

TransGen Biotech Co., Ltd is a leading supplier of laboratory reagents and instruments focusing on molecular biology, cell biology and immunology since 2006. With expertise in scientific research, we provides more than 200 self-developed and world-recognized products covering upstream to downstream of life sciences and biotech industry (ISO 9001 and ISO13285 obtained).

Read More

Transcend

Transcend is the data permissioning layer that unlocks health data activation, AI, and monetization at scale. While fragmented permissions across EHRs and portals often bottleneck innovation, Transcend centralizes patient consent into a unified source of truth. We replace disconnected workflows with real-time enforcement across your entire tech stack, ensuring compliance is an enabler rather than a blocker. By bridging the gap between data silos and action, Transcend empowers health systems to: – Personalize outreach and engagement. – Accelerate AI initiatives safely. – Unlock new revenue streams through secure data monetization. Drive better outcomes with data that is finally usable. | Transcend is the compliance layer for patient data, enabling healthcare organizations to activate AI and data-driven initiatives responsibly and at scale. Health systems and healthcare innovators rely on Transcend to embed HIPAA-compliant governance and privacy controls directly into their technology stacks. By replacing manual, fragmented workflows with a unified, system-level layer, Transcend enforces data permissions in real-time across patient data stores, cloud platforms, and AI systems.

Read More

TOYOBO USA

In the 1950s, TOYOBO began investigating microorganisms for treating waste water from one of our plants that processed pulp for rayon. Scientists in our laboratories discovered that a certain type of yeast was consuming sugar in the waste water, substantially reducing the biochemical oxygen demand (BOD) level. We then filtered out the yeast to market it for animal food. As the proportion of nucleic acids in the yeast was extremely high, we separated them out and did research for use in food seasonings. In the 1960s, based on a success in commercializing uricase from Candida sp., the first of its kind, we expanded our focus to include the field of clinical chemistry. Now TOYOBO excels in the market with more than 60 kinds of material enzymes for diagnostic reagents. We also provide many kinds of materials and kits for research use at the forefront of the field of molecular biology. TOYOBO Healthcare products are renowned both in Japan and around the world for the finest level of quality on the market.

Read More